NOVA | NOVA WELLNESS GROUP BERHAD

0.520 (0.0%)
2

T-O (am): 0.520 (08:59:00)
T-O (pm): 0.520 (14:29:00)
Last updated: 17:00

Fundamental
Technical
Total Score
NOVA | NOVA WELLNESS GROUP BERHAD


Support & Resistance

ATR Trailing Stop: 0.52

Support
Last Price
Resistance
Price 0.5 0.505 0.51 0.515 0.52 0.52 0.52 0.545 0.55 0.555 0.57
Volume (M) 5.8 7.2 4.8 12.4 15.0 15.0 16.9 36.1 7.3 17.8

Gann Support: 0.49/0.46 | Resistance: 0.53/0.57

*Highlighted column shows significant volume at the support or resistance area.

Technical Trend

Trading Signals

Based on iSaham Screeners

Moving Average (Short Term)
Moving Average (Mid Term)
Moving Average (Long Term)
Ichimoku Kumo
Bollinger Band
RSI
Stochastic
Heikin-Ashi
MACD
Solid MA Trend
SAT
Sector Trend (Long Term)
Sector Trend (Short Term)
Institutional Holdings
Beat The Insti
Magic Formula
Better Than ASB
52-Week High
BTST
T+
Candlestick
Chart Pattern

Please be fully informed regarding the risks and costs associated with trading in the stock markets. Any trade you made must be followed by your own judgement and analysis. Please read our risk disclosure for more info.

Pivot Point

S2
S1
P
R1
R2
Daily 0.505 0.515 0.52 0.53 0.535
Weekly 0.495 0.505 0.53 0.54 0.565

iSaham Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Quarter Reports

Chart:

Select columns required and click "Update" to save your preferences

Ann. Date Qtr. Date Q FYE Revenue [M] PBT [M] NP [M] NPM DPS EPS R. QoQ R. YoY E. QoQ E. YoY TTM
EPS		 Adj.
[M]		 NP [M]
(adj)		 NPM
(adj)		 EPS
(adj)		 E. QoQ
(adj)		 E. YoY
(adj)		 TTM EPS
(adj)
20 Feb 24 Q2 Dec 23 2 30 Jun 24 10.22 3.67 3.01 29.4% 0.00 0.96 2.2% 14.9% 15.7% 29.8%
07 Nov 23 Q1 Sep 23 1 30 Jun 24 10.45 3.15 2.60 24.9% 0.00 0.82 0.3% 13.0% 26.0% 39.2%
18 Aug 23 Q4 Jun 23 4 30 Jun 23 10.48 4.57 3.51 33.5% 0.00 1.10 5.1% 1.0% 19.5% 143.1%
23 May 23 Q3 Mar 23 3 30 Jun 23 11.04 3.90 2.94 26.6% 0.00 0.93 8.0% 8.0% 31.4% 39.8%
21 Feb 23 Q2 Dec 22 2 30 Jun 23 12.00 5.66 4.28 35.7% 2.05 1.35 0.0% 0.7% 0.2% 3.0%
16 Nov 22 Q1 Sep 22 1 30 Jun 23 12.01 5.64 4.27 35.6% 0.00 1.34 13.4% 17.0% 195.9% 17.9%
25 Aug 22 Q4 Jun 22 4 30 Jun 22 10.59 1.73 1.44 13.6% 1.25 0.45 11.8% 5.7% 70.4% 67.1%
24 May 22 Q3 Mar 22 3 30 Jun 22 12.00 5.65 4.88 40.7% 0.00 1.54 0.7% 17.6% 10.6% 41.1%
22 Feb 22 Q2 Dec 21 2 30 Jun 22 12.09 5.86 4.41 36.5% 2.00 1.39 16.4% 20.8% 15.2% 8.8%
16 Nov 21 Q1 Sep 21 1 30 Jun 22 14.46 6.88 5.20 36.0% 0.00 1.64 28.8% 59.8% 18.7% 93.4%
09 Sep 21 Q4 Jun 21 4 30 Jun 21 11.23 5.59 4.38 39.0% 0.00 1.38 10.0% 5.1% 26.7% 10.7%
18 May 21 Q3 Mar 21 3 30 Jun 21 10.20 4.78 3.46 33.9% 0.00 1.09 2.0% 16.2% 14.7% 27.1%
09 Feb 21 Q2 Dec 20 2 30 Jun 21 10.00 5.38 4.06 40.5% 1.80 1.28 10.6% 13.4% 50.8% 14.4%
16 Nov 20 Q1 Sep 20 1 30 Jun 21 9.05 3.56 2.69 29.7% 0.00 0.85 15.3% 51.0% 45.2% 44.6%
18 Aug 20 Q4 Jun 20 4 30 Jun 20 10.68 6.67 4.91 46.0% 0.00 1.54 21.7% 10.9% 80.3% 13.0%
21 May 20 Q3 Mar 20 3 30 Jun 20 8.78 3.65 2.72 31.0% 0.00 0.86 0.5% 21.2% 23.2% 33.5%
25 Feb 20 Q2 Dec 19 2 30 Jun 20 8.82 4.73 3.54 40.2% 0.55 1.12 47.2% 12.0% 90.6% 15.1%
27 Nov 19 Q1 Sep 19 1 30 Jun 20 5.99 2.48 1.86 31.0% 0.00 0.59 37.7% 24.6% 67.0% 119.9%
26 Aug 19 Q4 Jun 19 4 30 Jun 19 9.63 6.62 5.64 58.6% 0.00 1.77 33.0% 19.4% 176.6% 133.8%
16 May 19 Q3 Mar 19 3 30 Jun 19 7.24 3.27 2.04 28.2% 0.00 0.64 8.1% 52.3% 33.8% 47.8%
27 Feb 19 Q2 Dec 18 2 30 Jun 19 7.88 4.34 3.08 39.1% 0.50 0.99 63.8% 264.1%
29 Nov 18 Q1 Sep 18 1 30 Jun 19 4.81 1.33 0.85 17.6% 0.00 0.28 40.4% 64.9%
28 Aug 18 Q4 Jun 18 4 30 Jun 18 8.06 3.43 2.41 29.9% 0.00 1.49 69.7% 74.8%
12 Jul 18 Q3 Mar 18 3 30 Jun 18 4.75 1.81 1.38 29.0% 0.00 1.00

Historical Dividends

Financial Ratios

EPS 3.78 sen
Trailing PE (Sector Median: 18.2) 13.7
PEG 13.7
Altman Z 1.9
Beaver 0.604
Current Ratio 9.16
Debt-Equity (DE) Ratio 0.11
FCF Yield 3.47 %
Revenue QoQ -2.17 %
Revenue YoY -14.87%
Profit QoQ 15.74 %
Profit YoY -29.78 %
Profit Margin (Sector Median: 9.5) 28.57 %
ROE (ROIC: 11.21) 11.21 %
Dividend Per Share (DPS) 0.0 sen
Dividend Yield (DY) 0.0 %

Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 18.2)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: 9.5)
ROE (ROIC: 11.25)
Altman Z

Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Average Analysts FV based on 2 rating(s)
Graham Formula
Graham Number
Net Tangible Asset (NTA) 0.34
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M] 2.96
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 43.37
Expected Revenue (M) 114.6
Expected Growth (%) 20.0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

Directors Share Purchases (Beta)


No transaction in the last 2 months.

Summary


Market Cap: 165 M.

Number of Shares: 318 M.

Adjusted Float: 25.9%.

Stock highly correlated with

ARREIT (94%)

KOBAY (94%)

CARLSBG (93%)

CENGILD (93%)

Nova Wellness Group Berhad, an investment holding company, engages in developing, producing, and selling nutraceutical and skincare products. It provides dietary supplements, including vitamin, mineral, and herbal supplements under the Nova brand; and functional food products under the ActivMax and Sustinex brands. The company also offers skincare products under the brands Novavis and SP8. In addition, it provides original equipment manufacturers services for manufacturing dietary supplements and functional food products. Nova Wellness Group Berhad was founded in 1989 and is headquartered in Sungai Pelek, Malaysia

Sectors: Pharmaceuticals, Healthcare

Code: 0201

Website: http://www.nova.com.my/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

Top Shareholdings

Updated on 1-Sep-2023

Shareholder % Value (M)
Tan Sok Mooi 42.38% 70.24
Phang Yeen Nung 15.84% 26.25
Phang Nyie Lin 7.92% 13.13
Phang Yeen Aun 7.92% 13.13
Thien Chuk Kuen 2.49% 4.13
Eastspring Investments Small-Cap Fund 2.25% 3.73
Cartaban Nominees (Tempatan) Sdn Bhd 1.72% 2.85
Ronie Tan Choo Seng 1.67% 2.77
Tan Soon Hock 1.43% 2.37
Chee Sai Mun 0.79% 1.31
Yong Thian Fook 0.7% 1.16
Chan Huasheng 0.66% 1.09
Chan Huater 0.65% 1.08
Seik Thye Kong 0.38% 0.63
Wong Ai Ming 0.32% 0.53
Teh Kian Lang 0.3% 0.5
Shazwi Nabila Binti Munavvar Zubaid 0.2% 0.33
Teoh Hui Peng 0.2% 0.33
Zaliha Christine Binti Abdullah 0.15% 0.25
Mah Siew Hoe 0.14% 0.23
Yeap Sie Chung 0.14% 0.23
Denis Goh Chuan Hu 0.14% 0.23
Ngoh Ah Ban 0.13% 0.22
Ting Kong Wee 0.13% 0.22
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.